CDKN1A and non-small cell lung carcinoma: For example, lower expression of miR-17 and miR-92 families regulates cyclin-dependent kinase inhibitor 1A (CDKN1A) and RAD21 cohesin complex component (RAD21) in cisplatin-resistant NSCLC (Zhao J. et al., 2015a).